Chemed Corporation EBITDA 2011-2026 | CHE

Earnings before Interest, Taxes, Depreciation, and Amortization (EBITDA), is an often used measure of a company's profitability. Financial analysts use EBITDA for a number of purposes including calculating simple valuations of a firm, estimating cash flows, and assessing debt servicing capability. The uses for EBITDA in financial analysis are numerous, but in practice should be more restrained. While EBITDA has some useful applications, it should be used with caution, as the problems with EBITDA are abundant and can lead to a number of misguided conclusions.^[1]

EBITDA is an important indicator for investors and analysts because it allows them to evaluate a company's operating profit without considering the impact of financial expenses, taxes, or non-cash depreciation and amortization. It provides better comparability between companies in different industries or with different tax conditions.

EBITDA is often used to assess a company's ability to generate cash flow and repay debts. It can also serve as a measure of a company's operational efficiency, as it shows how profitable the core business is, regardless of external factors such as interest or taxes.

However, it is important to note that EBITDA is not an official financial statement measure and can be defined and calculated differently by companies. Therefore, investors and analysts should exercise caution when using EBITDA as an evaluation tool and combine it with other financial metrics and information to get a more complete picture of a company's financial condition.

Annual EBITDA Chemed Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
430 M	401 M	403 M	402 M	446 M	312 M	284 M	240 M	213 M	218 M	201 M	192 M	187 M	183 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
446 M	183 M	294 M

Quarterly EBITDA Chemed Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
88.4 M	81.8 M	111 M	105 M	101 M	88.1 M	99.7 M	82.1 M	87.6 M	-	93 M	105 M	104 M	-	138 M	85.3 M	94.7 M	-	117 M	121 M	93.2 M	-	96 M	86 M	59.7 M	-	90.5 M	77.2 M	65.7 M	-	80.7 M	-21.1 M	50.4 M	-	68.8 M	55.6 M	52.9 M	-	74.7 M	61 M	48.7 M	-	64.5 M	57.7 M	43.8 M	-	36.2 M	32.8 M	45.6 M	-	42.5 M	45.9 M	41.2 M	-	47.6 M	42.2 M	36.8 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
138 M	-21.1 M	72.9 M

References

Brockman, C. M., & Russell, J. W. (2012). EBITDA: use it... or lose it?. International Journal of Business, Accounting and Finance, 6(2), 84-93.

EBITDA of other stocks in the Care facilities industry

Issuer	EBITDA	Price	% 24h	Market Cap	Country
Amedisys AMED	121 M	-	0.01 %	$ 3.3 B	USA
Мать и Дитя MDMG	8.13 B	-	-	-	Russia
Apollo Medical Holdings AMEH	102 M	-	-2.11 %	$ 1.84 B	USA
Acadia Healthcare Company ACHC	150 M	$ 22.66	-2.22 %	$ 2.08 B	USA
The Joint Corp. JYNT	7.47 M	$ 8.44	-0.59 %	$ 122 M	USA
Community Health Systems CYH	1.91 B	$ 2.92	-2.02 %	$ 390 M	USA
Avalon GloboCare Corp. AVCO	-4.75 M	-	26.45 %	$ 70.6 M	USA
Encompass Health Corporation EHC	328 M	$ 97.71	0.23 %	$ 9.82 B	USA
Genesis Healthcare, Inc. GEN	-162 M	-	-	$ 68.1 M	USA
COMPASS Pathways plc CMPS	-178 M	$ 5.15	-3.65 %	$ 348 M	Britain
MEDNAX MD	231 M	$ 20.74	0.58 %	$ 1.74 B	USA
Aesthetic Medical International Holdings Group Limited AIH	53.3 M	-	10.96 %	$ 46.2 M	China
Capital Senior Living Corporation CSU	-235 M	-	-2.09 %	$ 216 M	USA
Five Star Senior Living Inc. FVE	26.9 M	-	-0.32 %	$ 98.4 M	USA
New Frontier Health Corporation NFH	354 M	-	3.54 %	$ 1.5 B	USA
AMN Healthcare Services AMN	499 M	$ 18.62	1.25 %	$ 729 M	USA
American Shared Hospital Services AMS	3.37 M	$ 2.01	1.52 %	$ 13.1 M	USA
Hanger HNGR	105 M	-	-	$ 732 M	USA
Concord Medical Services Holdings Limited CCM	-394 M	$ 3.65	-1.35 %	$ 478 M	China
DaVita DVA	2.75 B	$ 154.25	1.23 %	$ 11.4 B	USA
National HealthCare Corporation NHC	173 M	$ 162.86	0.15 %	$ 2.52 B	USA
Phibro Animal Health Corporation PAHC	156 M	$ 54.68	1.63 %	$ 2.22 B	USA
Option Care Health OPCH	405 M	$ 28.39	-0.07 %	$ 4.6 B	USA
LHC Group LHCG	132 M	-	-	$ 5.27 B	USA
Elanco Animal Health Incorporated ELAN	680 M	$ 25.1	2.66 %	$ 12.5 B	USA
Addus HomeCare Corporation ADUS	155 M	$ 98.41	-1.37 %	$ 1.78 B	USA
Select Medical Holdings Corporation SEM	476 M	$ 16.27	0.03 %	$ 2 B	USA
Novo Integrated Sciences NVOS	-7.81 M	-	-13.87 %	$ 1.52 M	USA
Surgery Partners SGRY	566 M	$ 11.84	-1.21 %	$ 1.51 B	USA
Sanara MedTech SMTI	-540 K	$ 18.91	3.11 %	$ 157 M	USA
Tenet Healthcare Corporation THC	4.37 B	$ 197.81	-2.75 %	$ 17.8 B	USA
Healthcare Services Group HCSG	16.8 M	$ 19.38	-0.77 %	$ 1.4 B	USA
IMAC Holdings IMAC	-5.48 M	-	-1.77 %	$ 25.4 M	USA
Universal Health Services UHS	2.61 B	$ 186.93	-0.65 %	$ 11.9 B	USA
U.S. Physical Therapy USPH	109 M	$ 74.42	-1.09 %	$ 1.13 B	USA
ModivCare MODV	16.7 M	-	-25.23 %	$ 6.12 M	USA
The Ensign Group ENSG	530 M	$ 202.73	0.15 %	$ 11.6 B	USA
Oak Street Health OSH	-97 M	-	0.03 %	$ 9.53 B	USA
Brookdale Senior Living BKD	384 M	$ 13.85	-0.29 %	$ 3.26 B	USA
Fresenius Medical Care AG & Co. KGaA FMS	3.48 B	$ 22.01	0.55 %	$ 7.05 B	Germany
HCA Healthcare HCA	3.52 B	$ 483.05	-2.34 %	$ 114 B	USA
Ontrak OTRK	-17.2 M	-	-11.98 %	$ 1.53 M	USA
Regional Health Properties RHE	2.22 M	-	-	$ 5.2 M	USA
SunLink Health Systems SSY	-1.04 M	-	17.98 %	$ 7.81 M	USA
Tivity Health TVTY	154 M	-	0.09 %	$ 1.6 B	USA
The Pennant Group PNTG	60.4 M	$ 30.62	-2.39 %	$ 1.06 B	USA